Two drug makers recently announced promising interim results for two COVID-19 vaccine candidates, but a University of Guelph viral immunologist says he has reservations. Prof. Byram Bridle studies oncolytic viruses (viruses that target cancer cells) in U of G’s Department of Pathobiology. He recently received provincial research funding to adapt the technology to develop a […]
Read More… from U of G Immunologist Has Concerns Over COVID-19 Vaccine Candidates